2014
DOI: 10.1002/elps.201400006
|View full text |Cite
|
Sign up to set email alerts
|

Recent advances in low‐cost microfluidic platforms for diagnostic applications

Abstract: The use of inexpensive materials and cost-effective manufacturing processes for mass production of microfluidic devices is very attractive and has spurred a variety of approaches. Such devices are particularly suited for diagnostic applications in limited resource settings. This review describes the recent and remarkable advances in the use of low-cost substrates for the development of microfluidic devices for diagnostics and clinical assays. Thus, a plethora of new and improved fabrication methods, designs, c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
54
0
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 129 publications
(58 citation statements)
references
References 141 publications
(169 reference statements)
0
54
0
1
Order By: Relevance
“…Other examples include the mChip, a device that tests whole blood for HIV using a combined microfluidic and protein-based immunoassay approach [58], and the Ativa Micro Lab (Ativa Medical, St. Paul, MN, USA), which was recently shown to execute a number of distinct blood tests with the use of a single device [59][60][61]. One upcoming technology is Ativa's portable Micro Lab, which has the potential to perform up to 25 distinct blood tests utilizing its various disposable test cards for each test.…”
Section: Current Commercial Poc Technologiesmentioning
confidence: 99%
See 1 more Smart Citation
“…Other examples include the mChip, a device that tests whole blood for HIV using a combined microfluidic and protein-based immunoassay approach [58], and the Ativa Micro Lab (Ativa Medical, St. Paul, MN, USA), which was recently shown to execute a number of distinct blood tests with the use of a single device [59][60][61]. One upcoming technology is Ativa's portable Micro Lab, which has the potential to perform up to 25 distinct blood tests utilizing its various disposable test cards for each test.…”
Section: Current Commercial Poc Technologiesmentioning
confidence: 99%
“…Thus, the common limitations of commercially available POC devices are accuracy, variations of cost per test, and the inability to simultaneously monitor multiple analytes. All of these factors are important and often required to make definitive diagnoses [61,[64][65][66][67]. As a consequence, research and engineering efforts are still required to address these factors to improve POC technology.…”
Section: Current Commercial Poc Technologiesmentioning
confidence: 99%
“…To validate the capability of fabricated channels as microfluidic devices, a "Y" design was used for fluid flow and theoretically compared with the literature (Figures 3(a)-3(c)). 5,8,10,11,14,16,18,20,[37][38][39][40][41][42][43] Other geometries were also fabricated (Figures 3(d) and 3(e)) to show the versatility of the targeted asymmetric calendaring and hydrophobization (TACH) method. The microfluidic devices were manufactured using paper and tested with dyed water (food color) for visualization.…”
Section: B Channel Fabricationmentioning
confidence: 99%
“…10 In the current study we have used cyclic polyolefins (COPs) which belong to a class of polymers employed due to their compatibility with biological materials, low autofluorescence, long shelf life and suitability for surface modification amongst others. 11,12 Multilayer alignment fabrication methodologies are commonly used to develop functional microdevices 13,14 , as lamination of polymer layers offers greater versatility and low cost. Zeonor® was chosen for this study, in conjunction with PSA (pressure sensitive adhesive), as both are suitable materials for simple fabrication and lamination methodologies.…”
Section: Introductionmentioning
confidence: 99%